The effect of early intensive insulin therapy on body fat distribution and β-cell function in newly diagnosed type 2 diabetes

Endocrine Research

Volumn 38, Issue 3, 2013, Pages 160-167

  Son, Jang Won ^a   Jeong, Hee Kyoung ^a   Lee, Seong Su ^a   Kim, Sung Rae ^a   Cha, Bong Yun ^a   Son, Ho Young ^a   Yoo, Soon Jib ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Body fat distribution; Diabetes mellitus; Insulin; Type 2

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; GLUCOSE BLOOD LEVEL; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; SKELETAL MUSCLE; SUBCUTANEOUS FAT;

EID: 84876451069     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.3109/07435800.2012.745870     Document Type: Article

References (32)

1. Ilkova H, Glaser B, Tunçkale A, Bagriaçik N, Cerasi E. Induction of long-Term glycaemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 1997;20:1353-1356 (Pubitemid 27366805)
2. Ryan EA, Imes S, Wallace C. Short-Term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 2004;27:1028-1032 (Pubitemid 38579760)
3. Li Y, Xu W, Liao Z, et al. Induction of long-Term glycaemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 2004;27:2597-2602 (Pubitemid 39441457)
4. Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: A multicentre randomized parallel-group trial. Lancet 2008;371:1753-1760 (Pubitemid 351697950)
5. Kissebach AH, Peiris AN. Biology of regional body fat distribution: Relationship to non-insulindependent diabetes mellitus. Diabetes Metab Rev 1989;5:83-109 (Pubitemid 19066635)
6. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996;45:633-638 (Pubitemid 26140548)
7. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761-811 (Pubitemid 24328939)
8. Klip A, Pâquet MR. Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 1990;13:228-243 (Pubitemid 20092110)
9. Kim TN, Yang SJ, Yoo HJ, et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: The Korean sarcopenic obesity study. Int J Obes (Lond) 2009;33:885-892
10. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-Associated insulin resistance and dysglycemia: Findings from the National Health and Nutrition Examination Survey III. PLoS One 2010;5:e10805
11. Ashford AJ, Pain VM. Insulin stimulation of growth in diabetic rats. Synthesis and degradation of ribosomes and total tissue protein in skeletal muscle and heart. J Biol Chem 1986;261:4066-4070 (Pubitemid 17198835)
12. Bennet WM, Connacher AA, Jung RT, Stehle P, Rennie MJ. Effects of insulin and amino acids on leg protein turnover in IDDM patients. Diabetes 1991;40:499-508
13. Denne SC, Liechty EA, Liu YM, Brechtel G, Baron AD. Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults. Am J Physiol 1991;261:E809-814
14. Meek SE, Persson M, Ford GC, Nair KS. Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes 1998;47:1824-1835 (Pubitemid 28549187)
15. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: Epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140
16. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: A practical guide. Int J Obes Relat Metab Disord 1993;17:187-196 (Pubitemid 23133348)
17. Heymsfield SB, Smith R, Aulet M, et al. Appendicular skeletal muscle mass: Measurement by dual photon absorptiometry. Am J Clin Nutr 1990;52:214-218
18. Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: Estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 2002;76:378-383 (Pubitemid 34804060)
19. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889-896 (Pubitemid 34496687)
20. Seino Y, Ikeda M, Yawata M, Imura H. The insulinogenic index in secondary diabetes. Horm Metab Res 1975;7:107-115
21. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470 (Pubitemid 29418240)
22. Juurinen L, Tiikkainen M, Häkkinen AM, Hakkarainen A, Yki-Järvinen H. Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2007;292:E829-835 (Pubitemid 46411061)
23. Shah PK, Mudaliar S, Chang AR, et al. Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes. Diabetes Obes Metab 2011;13:505-510
24. Takei I, Takayama S, Yamauchi A, et al. Effect of insulin therapy on body fat distribution in NIDDM patients with secondary sulfonylurea failure: A preliminary report. Eur J Clin Nutr 1998;52:153-154 (Pubitemid 28064086)
25. Yki-Järvinen H, Esko N, Eero H, Marja-Riitta T. Clinical benefits and mechanisms of sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. Am J Med 1988;84:185-192 (Pubitemid 18067428)
26. Kanauchi M, Tsujimoto N, Hashimoto T. Validation of simple indices to assess insulin sensitivity based on the oral glucose tolerance test in the Japanese population. Diabetes Res Clin Pract 2002;55:229-235 (Pubitemid 34163294)
27. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995;27:435-438
28. McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 2002;109:595-601 (Pubitemid 34204838)
29. Etgen GJ Jr, Jensen J, Wilson CM, et al. Exercise training reverses insulin resistance in muscle by enhanced recruitment of GLUT-4 to the cell surface. Am J Physiol 1997;272:E864-869
30. Fiebig RG, Hollander JM, Ney D, et al. Training down-regulates fatty acid synthase and body fat in obese Zucker rats. Med Sci Sports Exerc 2002;34:1106-1114 (Pubitemid 34747411)
31. Christ CY, Hunt D, Hancock J, et al. Exercise training improves muscle insulin resistance but not insulin receptor signaling in obese Zucker rats. J Appl Physiol 2002;92:736-744 (Pubitemid 34671044)
32. Argilés JM, López-Soriano J, Almendro V, Busquets S, López-Soriano FJ. Cross-Talk between skeletal muscle and adipose tissue: A link with obesity? Med Res Rev 2005;25:49-65 (Pubitemid 39628526)